Torrent Pharma ka share bhaga! Q3 mein **26%** profit jump, aur JB Pharma deal bhi pakki!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Torrent Pharma ka share bhaga! Q3 mein **26%** profit jump, aur JB Pharma deal bhi pakki!
Overview

Yaar, Torrent Pharma ne Q3 mein kamaal kar diya! Profit **26.2%** badh kar **₹635 Crore** ho gaya, aur revenue bhi **17.6%** upar **₹3,303 Crore** pahunch gaya. Plus, unhone JB Pharma mein bhi stake le liya hai!

Torrent Pharma ki Q3 performance aur JB Pharma deal ka pura update

Chalo, ab detail mein dekhte hain kya hua. Company ka consolidated revenue 17.6% badh kar ₹3,303 Crore pahuncha, jo pichhle saal is quarter mein ₹2,809 Crore tha. Aur profit? Woh toh 26.2% tezi se ₹635 Crore ho gaya, last year ye ₹503 Crore tha. Company ka Operating EBITDA bhi 19% badh kar ₹1,088 Crore raha, aur margins 33% par stable rahe. Ye sab cost management achhi hone ki nishani hai.

Financial health ki baat karein toh Torrent Pharma ki debt-to-equity ratio sudhar kar 0.21 ho gayi hai, jo bahut achha sign hai. Unhone ₹143 Crore ke debentures bhi repay kar diye. Aur shareholders ke liye khushkhabri – company ne ₹29 per share ka interim dividend bhi announce kiya hai. Paisa shareholders ko wapas mil raha hai!

Ab aate hain sabse badi khabar par – JB Pharma deal! Torrent Pharma ne J.B. Chemicals & Pharmaceuticals (JB Pharma) mein 48.8% controlling stake acquire kar liya hai. Ye ek strategic move hai jiska aim hai synergies ka fayda uthana, product portfolio extend karna aur market share badhana. Ab dono mil kar aur bade player banenge.

Alag-alag regions ki performance dekhein toh India mein revenue 14% badh kar ₹1,798 Crore ho gaya. Brazil mein 27% ki tez growth aayi, ₹371 Crore tak pahuncha. US mein bhi 19% growth se ₹321 Crore kamaye. Germany mein 8% growth dekhne ko mili, jo ₹304 Crore raha, haalanki thode supply issues ne thoda effect kiya.

Future ki baat karein toh German supply issues ek chhota challenge ho sakta hai, aur JB Pharma integration bhi careful handling mangta hai. Lekin overall outlook positive lag raha hai, especially JB Pharma deal ke baad company aur strong ho sakti hai.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.